CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: amoxapine
Accession: CHEBI:2675
browse the term
Definition: A dibenzooxazepine compound having a chloro substituent at the 2-position and a piperazin-1-yl group at the 11-position.
Synonyms: exact_synonym: 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine
related_synonym: 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine; Desmethylloxapin; Formula=C17H16ClN3O; InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2; InChIKey=QWGDMFLQWFTERH-UHFFFAOYSA-N; SMILES=Clc1ccc2Oc3ccccc3N=C(N3CCNCC3)c2c1; amoxapina; amoxapinum
xref: Beilstein:832057; CAS:14028-44-5; DrugBank:DB00543; Drug_Central:191; KEGG:D00228; LINCS:LSM-2021
xref_mesh: MESH:D000657
xref: PMID:24134630; Patent:FR1508536; Patent:US3663696; Wikipedia:Amoxapine
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
increases chemical synthesis
ISO
CYP3A4 results in increased chemical synthesis of Amoxapine
CTD
PMID:21826677
NCBI chr12:14,321,771...14,343,886
Ensembl chr12:14,321,771...14,343,857
G
Drd1
dopamine receptor D1
affects binding
ISO
Amoxapine binds to DRD1 protein
CTD
PMID:11180191
NCBI chr17:10,545,488...10,550,029
Ensembl chr17:10,545,111...10,567,166
G
Drd2
dopamine receptor D2
affects binding
ISO
Amoxapine binds to DRD2 protein
CTD
PMID:11180191
NCBI chr 8:58,605,403...58,669,339
Ensembl chr 8:58,605,403...58,669,339
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
multiple interactions
ISO
Amoxapine results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]; Amoxapine results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr 3:60,353,990...60,518,110
Ensembl chr 3:60,354,146...60,518,104
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
multiple interactions
ISO
Amoxapine results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ5 mRNA]
CTD
PMID:22164246
NCBI chr 8:38,981,598...39,011,197
Ensembl chr 8:38,983,034...39,011,101
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
multiple interactions
ISO
Amoxapine results in decreased activity of [KCNJ3 mRNA co-treated with KCNJ6 mRNA]
CTD
PMID:22164246
NCBI chr11:47,531,312...47,778,348
Ensembl chr11:47,531,312...47,778,348
G
Prl
prolactin
increases expression
ISO
Amoxapine results in increased expression of PRL protein
CTD
PMID:6363397
NCBI chr17:38,287,355...38,298,234
Ensembl chr17:38,288,162...38,298,217
G
Tac1
tachykinin, precursor 1
decreases expression
EXP
Amoxapine results in decreased expression of TAC1 protein
CTD
PMID:8955926
NCBI chr 4:36,645,344...36,653,548
Ensembl chr 4:36,645,571...36,653,546
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all